title: Urinary eosinophil protein X in childhood asthma: relation with changes in disease control and eosinophilic airway inflammation.
abstract: The aim of this study was to assess cross-sectional and longitudinal correlations between uEPX and other markers of asthma control and eosinophilic airway inflammation. Methods. We measured uEPX at baseline, after 1 year and after 2 years in 205 atopic asthmatic children using inhaled fluticasone. At the same time points, we assessed symptom scores (2 weeks diary card), lung function (forced expiratory volume in one second (FEV(1))), airway hyperresponsiveness (AHR), and percentage eosinophils in induced sputum (% eos). Results. We found negative correlations between uEPX and FEV(1) at baseline (r = -0.18, P = 0.01), after 1 year (r = -0.25, P < 0.01) and after 2 years (r = -0.21, P = 0.02). Within-patient changes of uEPX showed a negative association with FEV(1) changes (at 1 year: r = -0.24, P = 0.01; at 2 years: r = -0.21, P = 0.03). Within-patient changes from baseline of uEPX correlated with changes in % eos. No relations were found between uEPX and symptoms. Conclusion. In this population of children with atopic asthma, uEPX correlated with FEV(1) and % eos, and within-subjects changes in uEPX correlated with changes in FEV(1) and % eos. As the associations were weak and the scatter of uEPX wide, it seems unlikely that uEPX will be useful as a biomarker for monitoring asthma control in the individual child.
authors: Department of Pediatric Respiratory Medicine, Juliana Children's Hospital, HAGA Teaching Hospital, P.O. Box 60605, 2506 LP, The Hague, The Netherlands.
authors: Marianne
authors: M
authors: Nuijsink
authors: Wim C J
authors: WC
authors: Hop
authors: Peter J
authors: PJ
authors: Sterk
authors: Eric J
authors: EJ
authors: Duiverman
authors: Johan C
authors: JC
authors: De Jongste
mesh_terms: D000293:Adolescent; D001249:Asthma / Q000276:immunology* / Q000473:pathology / Q000652:urine*; D002648:Child; D047208:Eosinophil-Derived Neurotoxin / Q000652:urine*; D004804:Eosinophils / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D007249:Inflammation / Q000652:urine*; D008297:Male
chemical_list: D047208:Eosinophil-Derived Neurotoxin
references: Allergol Immunopathol (Madr). 2002 Jul-Aug;30(4):225-31
references: 12199967
references: Mediators Inflamm. 2007;2007:49240
references: 17641730
references: J Allergy Clin Immunol. 1996 Jun;97(6):1179-87
references: 8648010
references: Eur Respir J Suppl. 2002 Sep;37:19s-23s
references: 12361358
references: Eur Respir J. 1996 Dec;9(12):2441-7
references: 8980951
references: Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):688-95
references: 9309980
references: Clin Exp Allergy. 1999 Jul;29(7):926-32
references: 10383593
references: Thorax. 1990 Mar;45(3):199-202
references: 2330552
references: Allergy. 2000 Jul;55(7):647-52
references: 10921464
references: Eur Respir J. 2007 Sep;30(3):457-66
references: 17537770
references: J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):353-7
references: 10669858
references: J Allergy Clin Immunol. 2001 May;107(5):812-7
references: 11344347
references: Clin Exp Allergy. 1998 Sep;28(9):1138-44
references: 9761018
references: Eur Respir J. 2000 Oct;16(4):588-92
references: 11106196
references: Allergy. 2000 Oct;55(10):964-8
references: 11030379
references: Allergy. 1997 May;52(5):584-8
references: 9201373
references: Clin Exp Allergy. 1999 Nov;29(11):1502-6
references: 10520078
references: Eur Respir J. 1999 Jun;13(6):1391-5
references: 10445617
references: Eur Respir J Suppl. 1993 Mar;16:5-40
references: 8499054
references: Eur Respir J. 1996 Nov;9(11):2231-5
references: 8947065
references: Clin Exp Allergy. 1999 Jun;29(6):786-93
references: 10336595
references: Pediatr Pulmonol. 2001 May;31(5):354-62
references: 11340681
references: Am J Respir Crit Care Med. 2000 Jan;161(1):9-16
references: 10619791
references: Am J Respir Crit Care Med. 2001 Dec 1;164(11):2107-13
references: 11739143
references: Clin Exp Allergy. 2005 Sep;35(9):1175-9
references: 16164444